Registry organizations: Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes
12 registry organizations linked to Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes, by name. Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 24 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 15 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 26 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 4 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 20 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 17 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 15 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 16 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 31 trials in this atlas.